• Allard, R., Leclerc, P., Tremblay, C.,Tannenbaum, T.N., 2010. Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes Care, 33, 1491-1493.

  • Alraddadi, B.M., Watson, J.T., Almarashi, A., Abedi, G.R., Turkistani, A., Sadran, M., Housa, A., Almazroa, M.A., Alraihan, N., Banjar, A., et al., 2016. Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014. Emerg Infect Dis, 22, 49-55.

  • Barron, E., Bakhai, C., Kar, P., Weaver, A., Bradley, D., Ismail, H., Knighton, P., Holman, N., Khunti, K., Sattar, N., et al., 2020. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol, 8, 813-822.

  • Buetti, N., Trimboli, P., Mazzuchelli, T., Lo Priore, E., Balmelli, C., Trkola, A., Conti, M., Martinetti, G., Elzi, L., Ceschi, A., et al., 2020a. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients. Endocrine, 70, 454-460.

  • Buetti, N., Wicky, P.H., Le Hingrat, Q., Ruckly, S., Mazzuchelli, T., Loiodice, A., Trimboli, P., Forni Ogna, V., De Montmollin, E., Bernasconi, E., et al., 2020b. SARS-CoV-2 detection in the lower respiratory tract of invasively ventilated ARDS patients. Crit Care, 24, 610.

  • Cao, Y., Jian, F., Wang, J., Yu, Y., Song, W., Yisimayi, A., Wang, J., An, R., Chen, X., Zhang, N., et al., 2023. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature, 614, 521-529.

  • Carabelli, A.M., Peacock, T.P., Thorne, L.G., Harvey, W.T., Hughes, J., Consortium, C.-G.U., Peacock, S.J., Barclay, W.S., De Silva, T.I., Towers, G.J., et al., 2023. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol, 21, 162-177.

  • Chan, J.F.W., Yuan, S.F., Zhang, A.J.X., Poon, V.K.M., Chan, C.C.S., Lee, A.C.Y., Fan, Z.M., Li, C., Liang, R.H., Cao, J.L., et al., 2020. Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19). Clinical Infectious Diseases, 71, 2139-2149.

  • Chan, J.F., Hu, B., Chai, Y., Shuai, H., Liu, H., Shi, J., Liu, Y., Yoon, C., Zhang, J., Hu, J.C., et al., 2022. Virological features and pathogenicity of SARS-CoV-2 Omicron BA.2. Cell Rep Med, 3, 100743.

  • Chen, H., Charlat, O., Tartaglia, L.A., Woolf, E.A., Weng, X., Ellis, S.J., Lakey, N.D., Culpepper, J., Moore, K.J., Breitbart, R.E., et al., 1996. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell, 84, 491-495.

  • Chen, N.S., Zhou, M., Dong, X., Qu, J.M., Gong, F.Y., Han, Y., Qiu, Y., Wang, J.L., Liu, Y., Wei, Y., et al., 2020. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 395, 507-513.

  • Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., et al., 2020. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ, 368, m1091.

  • Chen, P., Wu, M., He, Y., Jiang, B.,He, M.L., 2023. Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection. Signal Transduct Target Ther, 8, 237.

  • Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., Li, J., Yao, Y., Ge, S.,Xu, G., 2020. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int, 97, 829-838.

  • Coronaviridae Study Group of the International Committee on Taxonomy Of Virus, 2020. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol, 5, 536-544.

  • D'souza A, M., Neumann, U.H., Glavas, M.M.,Kieffer, T.J., 2017. The glucoregulatory actions of leptin. Mol Metab, 6, 1052-1065.

  • Davies, N.G., Abbott, S., Barnard, R.C., Jarvis, C.I., Kucharski, A.J., Munday, J.D., Pearson, C.a.B., Russell, T.W., Tully, D.C., Washburne, A.D., et al., 2021a. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science, 372, 6538.

  • Davies, N.G., Jarvis, C.I., Group, C.C.-W., Edmunds, W.J., Jewell, N.P., Diaz-Ordaz, K.,Keogh, R.H., 2021b. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7. Nature, 593, 270-274.

  • Diao, B., Wang, C., Wang, R., Feng, Z., Zhang, J., Yang, H., Tan, Y., Wang, H., Wang, C., Liu, L., et al., 2021. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection. Nat Commun, 12, 2506.

  • Dicker, D., Lev, S., Gottesman, T., Kournos, T., Dotan, M., Ashorov, N., Marcoviciu, D.,Golan, R., 2020. A Time Frame for Testing Negative for SARS-COV2 in People with Obesity. Obes Facts, 13, 528-533.

  • Drucker, D.J., 2021. Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning. Cell Metab, 33, 479-498.

  • Faria, N.R., Mellan, T.A., Whittaker, C., Claro, I.M., Candido, D.D.S., Mishra, S., Crispim, M.a.E., Sales, F.C.S., Hawryluk, I., Mccrone, J.T., et al., 2021. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science, 372, 815-821.

  • Gao, Y.D., Ding, M., Dong, X., Zhang, J.J., Kursat Azkur, A., Azkur, D., Gan, H., Sun, Y.L., Fu, W., Li, W., et al., 2020. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy, 76, 428-455.

  • Garreta, E., Prado, P., Stanifer, M.L., Monteil, V., Marco, A., Ullate-Agote, A., Moya-Rull, D., Vilas-Zornoza, A., Tarantino, C., Romero, J.P., et al., 2022. A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells. Cell Metab, 34, 857-873.e9.

  • Gogiraju, R., Witzler, C., Shahneh, F., Hubert, A., Renner, L., Bochenek, M.L., Zifkos, K., Becker, C., Thati, M.,Schafer, K., 2023. Deletion of endothelial leptin receptors in mice promotes diet-induced obesity. Sci Rep, 13, 8276.

  • Gu, H.J., Chen, Q., Yang, G., He, L., Fan, H., Deng, Y.Q., Wang, Y.X., Teng, Y., Zhao, Z.P., Cui, Y.J., et al., 2020. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy. Science, 369:1603-1607.

  • Hachmann, N.P., Miller, J., Collier, A.Y., Ventura, J.D., Yu, J., Rowe, M., Bondzie, E.A., Powers, O., Surve, N., Hall, K., et al., 2022. Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5. N Engl J Med, 387, 86-88.

  • Halfmann, P.J., Iida, S., Iwatsuki-Horimoto, K., Maemura, T., Kiso, M., Scheaffer, S.M., Darling, T.L., Joshi, A., Loeber, S., Singh, G., et al., 2022. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. Nature, 603, 687-692.

  • Hu, B., Chan, J.F., Liu, Y., Liu, H., Chen, Y.X., Shuai, H., Hu, Y.F., Hartnoll, M., Chen, L., Xia, Y., et al., 2024. Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tract. EBioMedicine, 99, 104916.

  • Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al., 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395, 497-506.

  • Huang, K., Zhang, Y.F., Hui, X.F., Zhao, Y., Gong, W.X., Wang, T., Zhang, S.R., Yang, Y., Deng, F., Zhang, Q., et al., 2021. Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice. Ebiomedicine, 67, 103381.

  • Huang, Q., An, R., Wang, H., Yang, Y., Tang, C., Wang, J., Yu, W., Zhou, Y., Zhang, Y., Wu, D., et al., 2023. Aggravated pneumonia and diabetes in SARS-CoV-2 infected diabetic mice. Emerg Microbes Infect, 12, 2203782.

  • Imai, M., Iwatsuki-Horimoto, K., Hatta, M., Loeber, S., Halfmann, P.J., Nakajima, N., Watanabe, T., Ujie, M., Takahashi, K., Ito, M., et al., 2020. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc Natl Acad Sci U S A, 117, 16587-16595.

  • Jiang, R.D., Liu, M.Q., Chen, Y., Shan, C., Zhou, Y.W., Shen, X.R., Li, Q., Zhang, L., Zhu, Y., Si, H.R., et al., 2020. Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2. Cell, 182, 50-58.e8.

  • Johnson, R.M., Ardanuy, J., Hammond, H., Logue, J., Jackson, L., Baracco, L., Mcgrath, M., Dillen, C., Patel, N., Smith, G., et al., 2023. Diet-induced obesity and diabetes enhance mortality and reduce vaccine efficacy for SARS-CoV-2. J Virol, 97, e0133623.

  • Kronbichler, A., Gauckler, P., Windpessl, M., Il Shin, J., Jha, V., Rovin, B.H.,Oberbauer, R., 2020. COVID-19: implications for immunosuppression in kidney disease and transplantation. Nat Rev Nephrol, 16, 365-367.

  • Kwan, A.C., Ebinger, J.E., Botting, P., Navarrette, J., Claggett, B.,Cheng, S., 2023. Association of COVID-19 Vaccination With Risk for Incident Diabetes After COVID-19 Infection. JAMA Netw Open, 6, e2255965.

  • Li, B., Deng, A., Li, K., Hu, Y., Li, Z., Shi, Y., Xiong, Q., Liu, Z., Guo, Q., Zou, L., et al., 2022. Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant. Nat Commun, 13, 460.

  • Li, P., Faraone, J.N., Hsu, C.C., Chamblee, M., Liu, Y., Zheng, Y.M., Xu, Y., Carlin, C., Horowitz, J.C., Mallampalli, R.K., et al., 2024. Neutralization and Stability of JN.1-derived LB.1, KP.2.3, KP.3 and KP.3.1.1 Subvariants. bioRxiv, 10.1101/2024.09.04.611219.

  • Liang, L., Wang, W., Chen, J., Wu, W., Huang, X.R., Wei, B., Zhong, Y., Ma, R.C.W., Yu, X.,Lan, H.Y., 2023. SARS-CoV-2 N protein induces acute kidney injury in diabetic mice via the Smad3-Ripk3/MLKL necroptosis pathway. Signal Transduct Target Ther, 8, 147.

  • Lin, H.F., Liu, M.Q., Jiang, R.D., Gong, Q.C., Su, J., Guo, Z.S., Chen, Y., Jia, J.K., Dong, T.Y., Zhu, Y., et al., 2023. Characterization of a mouse-adapted strain of bat severe acute respiratory syndrome-related coronavirus. J Virol, 97, e0079023.

  • Liu, Y.,Rocklov, J., 2022. The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta. J Travel Med, 29, taac037.

  • Liu, J., Li, S., Liu, J., Liang, B., Wang, X., Wang, H., Li, W., Tong, Q., Yi, J., Zhao, L., et al., 2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine, 55, 102763.

  • Looi, M.K., 2023. Covid-19: WHO adds JN.1 as new variant of interest. BMJ, 383, 2975.

  • Maier, H.E., Lopez, R., Sanchez, N., Ng, S., Gresh, L., Ojeda, S., Burger-Calderon, R., Kuan, G., Harris, E., Balmaseda, A., et al., 2018. Obesity Increases the Duration of Influenza A Virus Shedding in Adults. J Infect Dis, 218, 1378-1382.

  • Mao, Y., Chen, Y., Li, Y., Ma, L., Wang, X., Wang, Q., He, A., Liu, X., Dong, T., Gao, W., et al., 2024. Deep spatial proteomics reveals region-specific features of severe COVID-19-related pulmonary injury. Cell Rep, 43, 113689.

  • Nobs, S.P., Kolodziejczyk, A.A., Adler, L., Horesh, N., Botscharnikow, C., Herzog, E., Mohapatra, G., Hejndorf, S., Hodgetts, R.J., Spivak, I., Schorr L, Fluhr L, Kviatcovsky D, Zacharia A, Njuki S, Barasch D, Stettner N, Dori-Bachash M, Harmelin A, Brandis A, Mehlman T, Erez A, He Y, Ferrini S, Puschhof J, Shapiro H, Kopf M, Moussaieff A, Abdeen SK, Elinav E, 2023. Lung dendritic-cell metabolism underlies susceptibility to viral infection in diabetes. Nature 624, 645-652.

  • Oliveira, S., Monteiro-Alfredo, T., Henriques, R., Ribeiro, C.F., Seica, R., Cruz, T., Cabral, C., Fernandes, R., Piedade, F., Robalo, M.P., et al., 2022. Improvement of Glycaemia and Endothelial Function by a New Low-Dose Curcuminoid in an Animal Model of Type 2 Diabetes. Int J Mol Sci, 23, 5652.

  • Oltolini, C., Acerbis, A., Orofino, G., Racca, S., Noviello, M., Dispinseri, S., Clementi, N., Piemontese, S., Xue, E., Giglio, F., et al., 2023. Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia. Front Immunol, 14, 1184956.

  • Puelles, V.G., Lutgehetmann, M., Lindenmeyer, M.T., Sperhake, J.P., Wong, M.N., Allweiss, L., Chilla, S., Heinemann, A., Wanner, N., Liu, S., et al., 2020. Multiorgan and Renal Tropism of SARS-CoV-2. N Engl J Med, 383, 590-592.

  • Puhach, O., Meyer, B.,Eckerle, I., 2023. SARS-CoV-2 viral load and shedding kinetics. Nat Rev Microbiol, 21, 147-161.

  • Rangu, R., Wander, P.L.,Zraika, S., 2022. Does diabetes risk after SARS-CoV-2 infection depend on the viral variant? Diabetes Res Clin Pract, 191, 110054.

  • Santus, P., Radovanovic, D., Saderi, L., Marino, P., Cogliati, C., De Filippis, G., Rizzi, M., Franceschi, E., Pini, S., Giuliani, F., et al., 2020. Severity of respiratory failure at admission and in-hospital mortality in patients with COVID-19: a prospective observational multicentre study. BMJ Open, 10, e043651.

  • Serreze, D.V., Wasserfall, C., Ottendorfer, E.W., Stalvey, M., Pierce, M.A., Gauntt, C., O'donnell, B., Flanagan, J.B., Campbell-Thompson, M., Ellis, T.M., et al., 2005. Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon. J Virol, 79, 1045-1052.

  • Shah, B.R.,Hux, J.E., 2003. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care, 26, 510-513.

  • Shuai, H., Chan, J.F., Hu, B., Chai, Y., Yuen, T.T., Yin, F., Huang, X., Yoon, C., Hu, J.C., Liu, H., et al., 2022. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. Nature, 603, 693-699.

  • Shuai, H., Chan, J.F., Hu, B., Chai, Y., Yoon, C., Liu, H., Liu, Y., Shi, J., Zhu, T., Hu, J.C., et al., 2023. The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5. EBioMedicine, 95, 104753.

  • Sia, S.F., Yan, L.M., Chin, A.W.H., Fung, K., Choy, K.T., Wong, A.Y.L., Kaewpreedee, P., Perera, R., Poon, L.L.M., Nicholls, J.M., et al., 2020. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature, 583, 834-838.

  • Singh, A.K.,Khunti, K., 2022. COVID-19 and Diabetes. Annu Rev Med, 73, 129-147.

  • Sun, S.H., Gu, H.J., Cao, L., Chen, Q., Ye, Q., Yang, G., Li, R.T., Fan, H., Deng, Y.Q., Song, X.P., et al., 2021. Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2. Nature Communications, 12, 5654.

  • Tang, X., Uhl, S., Zhang, T., Xue, D., Li, B., Vandana, J.J., Acklin, J.A., Bonnycastle, L.L., Narisu, N., Erdos, M.R., et al., 2021. SARS-CoV-2 infection induces beta cell transdifferentiation. Cell Metab, 33, 11577-1591.e7.

  • Tegally, H., Wilkinson, E., Giovanetti, M., Iranzadeh, A., Fonseca, V., Giandhari, J., Doolabh, D., Pillay, S., San, E.J., Msomi, N., et al., 2021. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature, 592, 438-443.

  • Toapanta, F.R.,Ross, T.M., 2009. Impaired immune responses in the lungs of aged mice following influenza infection. Respir Res, 10, 112.

  • Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al., 2020. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 323, 1061-1069.

  • Wang, X., Jiang, S., Ma, W., Zhang, Y.,Wang, P., 2024. Robust neutralization of SARS-CoV-2 variants including JN.1 and BA.2.87.1 by trivalent XBB vaccine-induced antibodies. Signal Transduct Target Ther, 9, 123.

  • Wu, C.T., Lidsky, P.V., Xiao, Y., Lee, I.T., Cheng, R., Nakayama, T., Jiang, S., Demeter, J., Bevacqua, R.J., Chang, C.A., et al., 2021. SARS-CoV-2 infects human pancreatic beta cells and elicits beta cell impairment. Cell Metab, 33, 1565-1576.e5.

  • Wu, W., Wang, W., Liang, L., Chen, J., Sun, S., Wei, B., Zhong, Y., Huang, X.R., Liu, J., Wang, X., et al., 2023. SARS-CoV-2 N protein induced acute kidney injury in diabetic db/db mice is associated with a Mincle-dependent M1 macrophage activation. Front Immunol, 14, 1264447.

  • Wysocki, J., Ye, M., Soler, M.J., Gurley, S.B., Xiao, H.D., Bernstein, K.E., Coffman, T.M., Chen, S.,Batlle, D., 2006. ACE and ACE2 activity in diabetic mice. Diabetes, 55, 2132-2139.

  • Xie, Y.,Al-Aly, Z., 2022. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol, 10, 311-321.

  • Yang, J.K., Feng, Y., Yuan, M.Y., Yuan, S.Y., Fu, H.J., Wu, B.Y., Sun, G.Z., Yang, G.R., Zhang, X.L., Wang, L., et al., 2006. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med, 23, 623-628.

  • Zhang, Z., Zhang, N., Lu, X., Zhou, M., Yan, X., Gu, W., Yang, J., Zhang, Q., Zhang, C., Gong, Y., et al., 2023. Anti-infection effects of heparin on SARS-CoV-2 in a diabetic mouse model. Zool Res, 44, 1003-1014.

  • Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al., 2020. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579, 270-273.

  • Zhu, N., Zhang, D.Y., Wang, W.L., Li, X.W., Yang, B., Song, J.D., Zhao, X., Huang, B.Y., Shi, W.F., Lu, R.J., et al., 2020. A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine, 382, 727-733.